Key Documents

View All Documentation

211265

4-Phenoxybenzaldehyde

Name: 4-Phenoxybenzaldehyde
Brand: ALDRICH

98%

Select a Size

Change View

About This Item

Linear Formula:

C₆H₅OC₆H₄CHO

CAS Number:

67-36-7

Molecular Weight:

198.22

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24852664

EC Number:

200-650-7

Beilstein/REAXYS Number:

1947841

MDL number:

MFCD00003383

Assay:

98%

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

98%

refractive index

n20/D 1.611 (lit.)

bp

185 °C/14 mmHg (lit.)

mp

24-25 °C (lit.)

density

1.132 g/mL at 25 °C (lit.)

functional group

aldehyde, phenoxy

SMILES string

O=Cc1ccc(Oc2ccccc2)cc1

InChI

1S/C13H10O2/c14-10-11-6-8-13(9-7-11)15-12-4-2-1-3-5-12/h1-10H

InChI key

QWLHJVDRPZNVBS-UHFFFAOYSA-N

Description

Application

4-Phenoxybenzaldehyde was used in the synthesis of:

spirodiketopiperazine derivatives
benzoxazoles

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

230.0 °F - closed cup

flash_point_c

110 °C - closed cup

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.

Rena Nishizawa et al.

Bioorganic & medicinal chemistry letters, 17(3), 727-731 (2006-11-23)

Hydroxylated derivatives were designed and synthesized based on the information of oxidative metabolites. Compounds derived from beta-substituted (2R,3R)-2-amino-3-hydroxypropionic acid showed improved inhibitory activities against the binding of MIP-1alpha to human CCR5, compared with the non-hydroxylated derivatives and the other isomers.

Novel non-benzimidazole chk2 kinase inhibitors.

Kelly J McClure et al.

Bioorganic & medicinal chemistry letters, 16(7), 1924-1928 (2006-01-31)

In a recent paper, [Arienti, K. L.; Brunmark, A.; Axe, F. U.; McClure, K. M.; Lee, A.; Blevitt, J.; Neff, D. K.; Huang, L.; Crawford, S.; Chennagiri, R. P.; Karlsson, L.; Brietenbucher, J. G. J. Med. Chem.2005, 48, 1873], we

Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents.

Vikas N Telvekar et al.

Bioorganic & medicinal chemistry letters, 22(1), 649-652 (2011-11-15)

A series of structurally novel, substituted 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives incorporating 2-hydrazinyl benzothiazole and 4-(aryloxy)benzaldehyde were designed and synthesized using molecular hybridization approach. All the synthesized compounds exhibited promising activity (MIC 1.5-29.00μg/ml) against Mycobacteriumtuberculosis H37Rv strains of using REMA. Five of

Global Trade Item Number

SKU	GTIN
211265-5G	04061836683078
211265-25G	04061836683061